DV
Dividend Vision

PFSA — Profusa, Inc. Common Stock

Profusa, Inc. Common Stock (PFSA)

Total return is -90.7% over the past 4.6 years, 178.3 points behind SPY at 87.6%. Its deepest 1-year drawdown was 99.9%.

Profusa, Inc. is a digital health technology company that develops bioengineered sensors designed to detect and continuously transmit clinical-grade data for medical and personal use. The company currently offers the Lumee Oxygen Platform for monitoring compromised tissue in conditions such as peripheral artery disease and chronic wounds, and is developing the Lumee Glucose Platform for glucose monitoring. Profusa does not currently distribute dividends and appeals primarily to growth-oriented investors focused on emerging medical device and digital health technologies.

PFSA key facts

Asset type
Stock
Asset class
Equity
Inception date
01/24/2022
Last close
$0.90
Market cap
$1,060,000
Average volume
84500.0
Beta
0.437
Payout ratio
0.0
Forward P/E
0.0
EPS
$-395.94